Table 1 |
||||||
|
Correlations between androgen receptor status and patient and tumour characteristics in all tumours and serous carcinomas respectively |
||||||
|
All tumours |
Serous carcinoma |
|||||
|
|
|
|||||
|
AR low |
AR high |
AR low |
AR high |
|||
|
|
||||||
|
126 |
28 |
p-value ± |
71 |
19 |
p-value ± |
|
|
|
||||||
|
Age |
||||||
|
median(range) |
62(47-83) |
63(50-79) |
0.800 |
63(47-83) |
64(50-79) |
0.514 |
|
Histological subtype |
||||||
|
Serous |
71 |
19 |
0.207 |
|||
|
Endometroid |
28 |
7 |
||||
|
Other |
27 |
2 |
||||
|
Stage |
||||||
|
I |
22 |
4 |
0.667 |
4 |
2 |
0.136 |
|
II |
16 |
2 |
5 |
2 |
||
|
III |
57 |
18 |
41 |
13 |
||
|
IV |
19 |
3 |
13 |
1 |
||
|
missing |
12 |
1 |
8 |
1 |
||
|
Differentiation grade |
||||||
|
High/intermediate |
37 |
10 |
0.511 |
14 |
7 |
0.015 |
|
low |
89 |
18 |
57 |
10 |
||
|
ER |
||||||
|
Negative |
62 |
5 |
0.003 |
28 |
2 |
0.024 |
|
Positive |
60 |
21 |
40 |
15 |
||
|
missing |
4 |
2 |
3 |
2 |
||
|
PR |
||||||
|
Negative |
103 |
18 |
0.033 |
61 |
15 |
0.676 |
|
Positive |
19 |
9 |
9 |
3 |
||
|
|
||||||
|
AR = androgen receptor, ER= estrogen receptor, PR= progesterone receptor < 10% positive nuclei used as cutoff for AR, ER and PR positivity ± Mann Whitney u-test for comparison of medians and Chi-square test for categorized variables Cases with missing values were not included in the analysis |
||||||
|
Nodin et al. Journal of Ovarian Research 2010 3:14 doi:10.1186/1757-2215-3-14 |
||||||
